Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tribute Pharmaceuticals Canada Inc (TBUFF)

Tribute Pharmaceuticals Canada Inc (TBUFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tribute Pharmaceuticals Canada Inc 151 Steeles Avenue East Milton A6 L9T 1Y1

www.tributepharma.com P: 519-434-1540

Description:

Tribute Pharmaceuticals Canada Inc. is a specialty pharmaceutical company engaged in the acquisition, licensing and management of prescription pharmaceuticals products primarily in Canada. Its products portfolio includes Cambia (R), Bezalip (R) SR, Soriatane (R), NeoVisc (R), Uracyst (R) and Collatamp G (R). The company focuses on various therapeutic areas, such as pain, urology, dermatology, and endocrinology/cardiology. Tribute Pharmaceuticals Canada Inc. is headquartered in Milton, Canada.

Key Statistics

Overview:

Market Capitalization, $K 119,550
Shares Outstanding, K 113,720
Annual Sales, $ 15,280 K
Annual Net Income, $ -5,080 K
Last Quarter Sales, $ 6,830 K
Last Quarter Net Income, $ 1,210 K
60-Month Beta 1.12
% of Institutional Shareholders 0.00%

Growth:

1-Year Return 64.60%
3-Year Return 132.50%
5-Year Return 56.30%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 03/01/16
Earnings Per Share ttm -0.03
EPS Growth vs. Prev Qtr 166.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payable Date 12/31/69
Dividend Payout Ratio 0.00%

TBUFF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 37.20
Price/Earnings to Growth N/A
Return-on-Equity % -8.90%
Return-on-Assets % -4.07%
Profit Margin % -33.25%
Debt/Equity 0.31
Price/Sales 6.00
Price/Cash Flow N/A
Price/Book 2.83
Book Value/Share 0.33
Interest Coverage 2.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar